A Two Year Study to Assess the Efficacy, Safety, and Tolerability of MK-0364 in Obese Patients Followed by a 1-Year Extension

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-002364-29

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

In obese patients, (1) to assess the effects of 2 or 4 mg MK-0364 after 1 year of treatment on body weight; (2) to assess the safety and tolerability of MK-0364 during base and extension studies.


Critère d'inclusion

  • obesity